Scipio Bioscience
A Paris-based biotechnology company .
Scipio Bioscience has raised €6.0M across 1 funding round from 1 investor, most recently a Series A round in Feb 2020. Based in Paris, France; founded 2017; active in Healthtech. Data as of 4 Nov 2026.
Total raised
€6.0M
€6,000,000
Funding rounds
1
Investors
1
distinct backers
Active since
2020-02
latest 2020-02
Funding by year
EUR raised per yearScipio Bioscience — funding by year — interactive chart.
Data table
| Scipio Bioscience — funding by year | |
|---|---|
| 2020 | €6.0M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-02-25 | Series A | €6.0M | M Ventures | View deal → |
Investors
1Related news
Similar companies
same sector, similar size- Ambler€7.5MFrance · Healthtech
- Hypno VR€5.2MFrance · Healthtech
- Quantificare€5.0MFrance · Healthtech
- Keen Eye€7.5MFrance · Healthtech
- BCV€6.0MFrance · Healthtech
- Damae Medical€7.0MFrance · Healthtech
Global coverage: FundingData